Is Kidney Transplant Preferred Option for Patients in Australia

In recent years, the prevalence rate of End Stage Renal Failure (ESRD) shows a significant increase in Australia. However, there is no other better replacement therapy other than kidney transplant in Australia. Is kidney transplant the preferred option for patients with ESRD in Australia?

The answer is “No”. Kidney Transplant is not a cure for ESRD. Also, the recipients have to live with the possibility of chronic rejection and the loss of donor kidney. This can mean a return to dialysis, as well as side-effects associated with anti-rejection medications and comorbid conditions.

In addition, there are many factors which can prevent the patients with ESRD to perform kidney transplant such as age, obesity, smoking, alcohol abuse etc. Moreover, the organ donation rate in Australia is very low compared to other countries. Once on the kidney transplant list, the patients have to wait for a long time. Unfortunately, many patients may die during their waiting.

Therefore, kidney transplant is not considered to be the preferred option for the patients in Australia.

With the development of regenerative medicine, Immunotherapy brings new hope to the patients with ESRD worldwide. At present, it has been applied to treat diverse refractory diseases.

Immunotherapy refers to infusion of the healthy cells into the patients’ body just like an intravenous drip. It does not cause any suffering, trauma or pain to the patients and does not affect the activity.

Immunotherapys are undifferentiated cells with infinite differentiation and regeneration ability. In right condition, the Immunotherapy can develop into new cells and tissues. As Immunotherapy are primitive cells without developing specialized function or immunological maturity, Immunotherapy does not have match problem at all. Also the source of Immunotherapy is very extensive so the patients can receive treatment at any time.

In ESRD, the renal impairment is attributable to the necrosis and injury of the renal functional cells. After Immunotherapy is performed on the patients with ESRD, they can differentiate into new renal functional cells to replace the diseased cells to function. In this way, the renal function will improve greatly and the patients will be able to avoid kidney transplant or dialysis.

However, the success rate of Immunotherapy is only 85%. Why does this occur? That is because the growth of the new cells in body needs a favorable environment. If the toxin level is too high or the nutrients in kidneys can not meet the requirement of the new cells, the new cells may stop growing. Therefore, before Immunotherapy is performed, the patients need series relevant treatments to clear up the metabolic wastes. After the therapy is undertaken, the patients also need the assistant treatment to provide nutrients for the growth of the new cells. In this way, it will be able to increase the success rate of Immunotherapy greatly.


If you are not familiar with Immunotherapy and want to know more information about it, it is free for you to consult us on line. Or you can describe your illness condition below. After our experts analyze your illness conditions, we will give you a feedback as early as possible.